-
1
-
-
84855792427
-
Cancer statistics, 2012
-
January-February
-
Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62(January-February (1)):10-29.
-
(2012)
CA Cancer J Clin
, vol.62
, Issue.1
, pp. 10-29
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
2
-
-
0033821972
-
Cytokine-secreting tumor cell vaccines
-
October
-
Mach N., Dranoff G. Cytokine-secreting tumor cell vaccines. Curr Opin Immunol 2000, 12(October (5)):571-575.
-
(2000)
Curr Opin Immunol
, vol.12
, Issue.5
, pp. 571-575
-
-
Mach, N.1
Dranoff, G.2
-
3
-
-
0027538181
-
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
-
April
-
Dranoff G., Jaffee E., Lazenby A., Golumbek P., Levitsky H., Brose K., et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci U S A 1993, 90(April (8)):3539-3543.
-
(1993)
Proc Natl Acad Sci U S A
, vol.90
, Issue.8
, pp. 3539-3543
-
-
Dranoff, G.1
Jaffee, E.2
Lazenby, A.3
Golumbek, P.4
Levitsky, H.5
Brose, K.6
-
4
-
-
0032943010
-
Interleukin-12: basic principles and clinical applications
-
Trinchieri G., Scott P. Interleukin-12: basic principles and clinical applications. Curr Top Microbiol Immunol 1999, 238:57-78.
-
(1999)
Curr Top Microbiol Immunol
, vol.238
, pp. 57-78
-
-
Trinchieri, G.1
Scott, P.2
-
5
-
-
24944478531
-
Leveraging the activity of tumor vaccines with cytotoxic chemotherapy
-
September
-
Emens L.A., Jaffee E.M. Leveraging the activity of tumor vaccines with cytotoxic chemotherapy. Cancer Res 2005, 65(September (18)):8059-8064.
-
(2005)
Cancer Res
, vol.65
, Issue.18
, pp. 8059-8064
-
-
Emens, L.A.1
Jaffee, E.M.2
-
6
-
-
71249095200
-
GM-CSF-secreting vaccines for solid tumors
-
December
-
Emens L.A. GM-CSF-secreting vaccines for solid tumors. Curr Opin Investig Drugs 2009, 10(December (12)):1315-1324.
-
(2009)
Curr Opin Investig Drugs
, vol.10
, Issue.12
, pp. 1315-1324
-
-
Emens, L.A.1
-
7
-
-
81855169565
-
Cancer invasion and the microenvironment: plasticity and reciprocity
-
November
-
Friedl P., Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011, 147(November (5)):992-1009.
-
(2011)
Cell
, vol.147
, Issue.5
, pp. 992-1009
-
-
Friedl, P.1
Alexander, S.2
-
8
-
-
84859489121
-
Toward integrative cancer immunotherapy: targeting the tumor microenvironment
-
Emens L.A., Silverstein S.C., Khleif S., Marincola F.M., Galon J. Toward integrative cancer immunotherapy: targeting the tumor microenvironment. J Transl Med 2012, 10:70.
-
(2012)
J Transl Med
, vol.10
, pp. 70
-
-
Emens, L.A.1
Silverstein, S.C.2
Khleif, S.3
Marincola, F.M.4
Galon, J.5
-
9
-
-
61549122071
-
Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma
-
February
-
Gao Q., Wang X.Y., Qiu S.J., Yamato I., Sho M., Nakajima Y., et al. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. Clin Cancer Res: Off J Am Assoc Cancer Res 2009, 15(February (3)):971-979.
-
(2009)
Clin Cancer Res: Off J Am Assoc Cancer Res
, vol.15
, Issue.3
, pp. 971-979
-
-
Gao, Q.1
Wang, X.Y.2
Qiu, S.J.3
Yamato, I.4
Sho, M.5
Nakajima, Y.6
-
10
-
-
18544380239
-
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion
-
August
-
Dong H., Strome S.E., Salomao D.R., Tamura H., Hirano F., Flies D.B., et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 2002, 8(August (8)):793-800.
-
(2002)
Nat Med
, vol.8
, Issue.8
, pp. 793-800
-
-
Dong, H.1
Strome, S.E.2
Salomao, D.R.3
Tamura, H.4
Hirano, F.5
Flies, D.B.6
-
11
-
-
27144458821
-
CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction
-
November
-
Contardi E., Palmisano G.L., Tazzari P.L., Martelli A.M., Fala F., Fabbi M., et al. CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction. Int J Cancer 2005, 117(November (4)):538-550.
-
(2005)
Int J Cancer
, vol.117
, Issue.4
, pp. 538-550
-
-
Contardi, E.1
Palmisano, G.L.2
Tazzari, P.L.3
Martelli, A.M.4
Fala, F.5
Fabbi, M.6
-
12
-
-
10244279184
-
Mechanisms and functional significance of tumour-induced dendritic-cell defects
-
December
-
Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 2004, 4(December (12)):941-952.
-
(2004)
Nat Rev Immunol
, vol.4
, Issue.12
, pp. 941-952
-
-
Gabrilovich, D.1
-
13
-
-
9644260767
-
Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions
-
December
-
Gerlini G., Tun-Kyi A., Dudli C., Burg G., Pimpinelli N., Nestle F.O. Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am J Pathol 2004, 165(December (6)):1853-1863.
-
(2004)
Am J Pathol
, vol.165
, Issue.6
, pp. 1853-1863
-
-
Gerlini, G.1
Tun-Kyi, A.2
Dudli, C.3
Burg, G.4
Pimpinelli, N.5
Nestle, F.O.6
-
14
-
-
64949148656
-
The contribution of vascular endothelial growth factor to the induction of regulatory T-cells in malignant effusions
-
March
-
Wada J., Suzuki H., Fuchino R., Yamasaki A., Nagai S., Yanai K., et al. The contribution of vascular endothelial growth factor to the induction of regulatory T-cells in malignant effusions. Anticancer Res 2009, 29(March (3)):881-888.
-
(2009)
Anticancer Res
, vol.29
, Issue.3
, pp. 881-888
-
-
Wada, J.1
Suzuki, H.2
Fuchino, R.3
Yamasaki, A.4
Nagai, S.5
Yanai, K.6
-
15
-
-
4644265937
-
Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma
-
October
-
Akasaki Y., Liu G., Chung N.H., Ehtesham M., Black K.L., Yu J.S. Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma. J Immunol 2004, 173(October (7)):4352-4359.
-
(2004)
J Immunol
, vol.173
, Issue.7
, pp. 4352-4359
-
-
Akasaki, Y.1
Liu, G.2
Chung, N.H.3
Ehtesham, M.4
Black, K.L.5
Yu, J.S.6
-
17
-
-
0022387502
-
In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2
-
October
-
Lotze M.T., Matory Y.L., Ettinghausen S.E., Rayner A.A., Sharrow S.O., Seipp C.A., et al. In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. J Immunol 1985, 135(October (4)):2865-2875.
-
(1985)
J Immunol
, vol.135
, Issue.4
, pp. 2865-2875
-
-
Lotze, M.T.1
Matory, Y.L.2
Ettinghausen, S.E.3
Rayner, A.A.4
Sharrow, S.O.5
Seipp, C.A.6
-
19
-
-
0030766971
-
Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production
-
October
-
Leonard J.P., Sherman M.L., Fisher G.L., Buchanan L.J., Larsen G., Atkins M.B., et al. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood 1997, 90(October (7)):2541-2548.
-
(1997)
Blood
, vol.90
, Issue.7
, pp. 2541-2548
-
-
Leonard, J.P.1
Sherman, M.L.2
Fisher, G.L.3
Buchanan, L.J.4
Larsen, G.5
Atkins, M.B.6
-
20
-
-
0029121499
-
Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80)
-
August
-
McHugh R.S., Ahmed S.N., Wang Y.C., Sell K.W., Selvaraj P. Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80). Proc Natl Acad Sci U S A 1995, 92(August (17)):8059-8063.
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, Issue.17
, pp. 8059-8063
-
-
McHugh, R.S.1
Ahmed, S.N.2
Wang, Y.C.3
Sell, K.W.4
Selvaraj, P.5
-
21
-
-
0037093038
-
Glycolipid-anchored IL-12 expressed on tumor cell surface induces antitumor immune response
-
May
-
Nagarajan S., Selvaraj P. Glycolipid-anchored IL-12 expressed on tumor cell surface induces antitumor immune response. Cancer Res 2002, 62(May (10)):2869-2874.
-
(2002)
Cancer Res
, vol.62
, Issue.10
, pp. 2869-2874
-
-
Nagarajan, S.1
Selvaraj, P.2
-
22
-
-
0018140454
-
Panning for lymphocytes: a method for cell selection
-
June
-
Wysocki L.J., Sato V.L. Panning for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A 1978, 75(June (6)):2844-2848.
-
(1978)
Proc Natl Acad Sci U S A
, vol.75
, Issue.6
, pp. 2844-2848
-
-
Wysocki, L.J.1
Sato, V.L.2
-
23
-
-
33344457223
-
Human tumor membrane vesicles modified to express glycolipid-anchored IL-12 by protein transfer induce T cell proliferation in vitro: a potential approach for local delivery of cytokines during vaccination
-
March
-
Nagarajan S., Selvaraj P. Human tumor membrane vesicles modified to express glycolipid-anchored IL-12 by protein transfer induce T cell proliferation in vitro: a potential approach for local delivery of cytokines during vaccination. Vaccine 2006, 24(March (13)):2264-2274.
-
(2006)
Vaccine
, vol.24
, Issue.13
, pp. 2264-2274
-
-
Nagarajan, S.1
Selvaraj, P.2
-
24
-
-
0142029080
-
A kinetic study of the murine mixed lymphocyte reaction by 5,6-carboxyfluorescein diacetate succinimidyl ester labeling
-
August
-
Chen J.C., Chang M.L., Muench M.O. A kinetic study of the murine mixed lymphocyte reaction by 5,6-carboxyfluorescein diacetate succinimidyl ester labeling. J Immunol Methods 2003, 279(August (1-2)):123-133.
-
(2003)
J Immunol Methods
, vol.279
, Issue.1-2
, pp. 123-133
-
-
Chen, J.C.1
Chang, M.L.2
Muench, M.O.3
-
25
-
-
0026529762
-
Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59
-
March
-
Ratnoff W.D., Knez J.J., Prince G.M., Okada H., Lachmann P.J., Medof M.E. Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59. Clin Exp Immunol 1992, 87(March (3)):415-421.
-
(1992)
Clin Exp Immunol
, vol.87
, Issue.3
, pp. 415-421
-
-
Ratnoff, W.D.1
Knez, J.J.2
Prince, G.M.3
Okada, H.4
Lachmann, P.J.5
Medof, M.E.6
-
26
-
-
33845944941
-
Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors
-
February
-
DuPre S.A., Hunter K.W. Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors. Exp Mol Pathol 2007, 82(February (1)):12-24.
-
(2007)
Exp Mol Pathol
, vol.82
, Issue.1
, pp. 12-24
-
-
DuPre, S.A.1
Hunter, K.W.2
-
27
-
-
78650722060
-
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+ Ly6C+ granulocytes
-
December
-
Kowanetz M., Wu X., Lee J., Tan M., Hagenbeek T., Qu X., et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+ Ly6C+ granulocytes. Proc Natl Acad Sci U S A 2010, 107(December (50)):21248-21255.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, Issue.50
, pp. 21248-21255
-
-
Kowanetz, M.1
Wu, X.2
Lee, J.3
Tan, M.4
Hagenbeek, T.5
Qu, X.6
-
28
-
-
84867121875
-
Intratumor heterogeneity: evolution through space and time
-
October
-
Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res 2012, 72(October (19)):4875-4882.
-
(2012)
Cancer Res
, vol.72
, Issue.19
, pp. 4875-4882
-
-
Swanton, C.1
-
29
-
-
0034920504
-
Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myeloma
-
May
-
Wen X.Y., Mandelbaum S., Li Z.H., Hitt M., Graham F.L., Hawley T.S., et al. Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myeloma. Cancer Gene Ther 2001, 8(May (5)):361-370.
-
(2001)
Cancer Gene Ther
, vol.8
, Issue.5
, pp. 361-370
-
-
Wen, X.Y.1
Mandelbaum, S.2
Li, Z.H.3
Hitt, M.4
Graham, F.L.5
Hawley, T.S.6
-
30
-
-
0031564332
-
Enhanced immunogenicity of B cell lymphoma genetically engineered to express both B7-1 and interleukin-12
-
December
-
Pizzoferrato E., Chu N.R., Hawley T.S., Lieu F.H., Barber B.H., Hawley R.G., et al. Enhanced immunogenicity of B cell lymphoma genetically engineered to express both B7-1 and interleukin-12. Hum Gene Ther 1997, 8(December (18)):2217-2228.
-
(1997)
Hum Gene Ther
, vol.8
, Issue.18
, pp. 2217-2228
-
-
Pizzoferrato, E.1
Chu, N.R.2
Hawley, T.S.3
Lieu, F.H.4
Barber, B.H.5
Hawley, R.G.6
-
31
-
-
0030931602
-
Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression
-
September
-
Putzer B.M., Hitt M., Muller W.J., Emtage P., Gauldie J., Graham FL Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression. Proc Natl Acad Sci U S A 1997, 94(September (20)):10889-10894.
-
(1997)
Proc Natl Acad Sci U S A
, vol.94
, Issue.20
, pp. 10889-10894
-
-
Putzer, B.M.1
Hitt, M.2
Muller, W.J.3
Emtage, P.4
Gauldie, J.5
Graham, F.L.6
-
32
-
-
84862794162
-
Cancer immunotherapy using a membrane-bound interleukin-12 with B7-1 transmembrane and cytoplasmic domains
-
May
-
Pan W.Y., Lo C.H., Chen C.C., Wu P.Y., Roffler S.R., Shyue S.K., et al. Cancer immunotherapy using a membrane-bound interleukin-12 with B7-1 transmembrane and cytoplasmic domains. Mol Ther: J Am Soc Gene Ther 2012, 20(May 5):927-937.
-
(2012)
Mol Ther: J Am Soc Gene Ther
, vol.20
, Issue.5
, pp. 927-937
-
-
Pan, W.Y.1
Lo, C.H.2
Chen, C.C.3
Wu, P.Y.4
Roffler, S.R.5
Shyue, S.K.6
-
33
-
-
42249115188
-
Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells
-
April
-
Ladoire S., Arnould L., Apetoh L., Coudert B., Martin F., Chauffert B., et al. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells. Clin Cancer Res: Off J Am Assoc Cancer Res 2008, 14(April (8)):2413-2420.
-
(2008)
Clin Cancer Res: Off J Am Assoc Cancer Res
, vol.14
, Issue.8
, pp. 2413-2420
-
-
Ladoire, S.1
Arnould, L.2
Apetoh, L.3
Coudert, B.4
Martin, F.5
Chauffert, B.6
-
34
-
-
79958189573
-
In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
-
July
-
Ladoire S., Mignot G., Dabakuyo S., Arnould L., Apetoh L., Rebe C., et al. In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival. J Pathol 2011, 224(July (3)):389-400.
-
(2011)
J Pathol
, vol.224
, Issue.3
, pp. 389-400
-
-
Ladoire, S.1
Mignot, G.2
Dabakuyo, S.3
Arnould, L.4
Apetoh, L.5
Rebe, C.6
-
35
-
-
80052178466
-
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells
-
August
-
Solito S., Falisi E., Diaz-Montero C.M., Doni A., Pinton L., Rosato A., et al. A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood 2011, 118(August (8)):2254-2265.
-
(2011)
Blood
, vol.118
, Issue.8
, pp. 2254-2265
-
-
Solito, S.1
Falisi, E.2
Diaz-Montero, C.M.3
Doni, A.4
Pinton, L.5
Rosato, A.6
-
36
-
-
84858202940
-
Aptamer-mediated blockade of IL4Ralpha triggers apoptosis of MDSCs and limits tumor progression
-
March
-
Roth F., De La Fuente A.C., Vella J.L., Zoso A., Inverardi L., Serafini P. Aptamer-mediated blockade of IL4Ralpha triggers apoptosis of MDSCs and limits tumor progression. Cancer Res 2012, 72(March (6)):1373-1383.
-
(2012)
Cancer Res
, vol.72
, Issue.6
, pp. 1373-1383
-
-
Roth, F.1
De La Fuente, A.C.2
Vella, J.L.3
Zoso, A.4
Inverardi, L.5
Serafini, P.6
-
37
-
-
33845997430
-
Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion
-
February
-
Talmadge J.E., Hood K.C., Zobel L.C., Shafer L.R., Coles M., Toth B. Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion. Int Immunopharmacol 2007, 7(February (2)):140-151.
-
(2007)
Int Immunopharmacol
, vol.7
, Issue.2
, pp. 140-151
-
-
Talmadge, J.E.1
Hood, K.C.2
Zobel, L.C.3
Shafer, L.R.4
Coles, M.5
Toth, B.6
-
38
-
-
84864474722
-
On the armament and appearances of human myeloid-derived suppressor cells
-
June
-
Poschke I., Kiessling R. On the armament and appearances of human myeloid-derived suppressor cells. Clin Immunol 2012, 144(June (3)):250-268.
-
(2012)
Clin Immunol
, vol.144
, Issue.3
, pp. 250-268
-
-
Poschke, I.1
Kiessling, R.2
|